Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Invested Capital (2021 - 2023)

Rani Therapeutics Holdings (RANI) has 3 years of Return on Invested Capital data on record, last reported at 1.99% in Q4 2023.

  • For Q4 2023, Return on Invested Capital fell 120.0% year-over-year to 1.99%; the TTM value through Dec 2023 reached 1.99%, down 120.0%, while the annual FY2022 figure was 0.65%, 1150.0% up from the prior year.
  • Return on Invested Capital reached 1.99% in Q4 2023 per RANI's latest filing, down from 1.67% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.16% in Q2 2021 and bottomed at 10.95% in Q3 2021.
  • Average Return on Invested Capital over 3 years is 1.94%, with a median of 0.68% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 1031bps in 2022, then crashed -120bps in 2023.
  • A 3-year view of Return on Invested Capital shows it stood at 0.41% in 2021, then tumbled by -94bps to 0.79% in 2022, then tumbled by -151bps to 1.99% in 2023.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 1.99% in Q4 2023, 1.67% in Q3 2023, and 0.79% in Q4 2022.